CMP.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: March 24, 2025
Report Source: 2025 2nd Quarter Report
Compumedics Ltd. Stock Analysis CMP.AX
Compumedics Ltd. engages in the research, development, manufacture, and distribution of medical equipment and associated technologies. The company is headquartered in Melbourne, Victoria and currently employs 175 full-time employees. The company went IPO on 2000-12-21. Its geographic segments include Americas, Australia and Asia Pacific, and Europe and the Middle East. The company sells all of its product offerings in this region, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The company provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. The company offers Brain Research technologies through the Compumedics Neuroscan brand. Compumedics Neuroscan technologies provide solutions for EEG, ERPs, Source Localization and Functional Neuroimaging. The company also provides solutions for sleep applications from high definition 4k full PSG to home sleep testing.
Read More Compumedics Ltd (CMP.AX) Chart
Key Statistics of Compumedics Ltd (CMP.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.28Volume
82.12KP/E Ratio (TTM)
-52 Week Range
Market Cap
56.93MAvg. Volume
13.17KDividend Yield
-Financial Metrics & Statements of Compumedics Ltd (CMP.AX)
FAQ's for Compumedics Ltd (CMP.AX)
- According to Musaffa’s Shariah screening methodology, Compumedics Ltd (CMP.AX) is currently classified as HALAL as of March 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.